Merck opens billion-dollar facility to make bladder cancer immunotherapy
Merck has opened a new vaccine manufacturing plant at its existing site in Durham, NC, which will make a shot that is an important part of the bladder cancer treatment paradigm. The company first ...
Merck has opened a new vaccine manufacturing plant at its existing site in Durham, NC, which will make a shot that is an important part of the bladder cancer treatment paradigm.
The company first ...
